Bausch Health Companies | VRX - Ebitda


Bausch Health Companies reported $1.08B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Amgen USD 3.86B 1.28B Mar/2026
ANI Pharmaceuticals USD 65.36M 5.76M Dec/2025
Aurora Cannabis CAD 3.7M 14.78M Mar/2026
Bausch Health Companies USD 1.08B 238M Jun/2026
Biogen USD 649.7M 76.5M Mar/2026
Bristol-Myers Squibb USD 4.24B 1.37B Mar/2026
Canopy Growth CAD -137M 134.13M Mar/2026
Corcept Therapeutics USD -49M 53.2M Mar/2026
Danaher USD 1.84B 81M Jun/2026
Drreddys Laboratories INR 8.63B 12.96B Mar/2026
Eli Lilly USD 10.29B 1.86B Mar/2026
Gilead Sciences USD 3.51B 489M Mar/2026
Nektar Therapeutics USD -38.9M 7.09M Mar/2026
Novo Nordisk DKK 37.36B 2.64B Jun/2026
Pacira USD 48.67M 8.43M Jun/2026
Perrigo USD 141.6M 1.34B Mar/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 90.82M 3.99M Dec/2025
Supernus Pharmaceuticals USD 31.6M 2.37M Jun/2026
Vertex Pharmaceuticals USD 1.19B 195.3M Mar/2026
Zoetis USD 939M 101M Dec/2025